Study of binding interaction of rivaroxaban with bovine serum albumin using multi-spectroscopic and molecular docking approach

BACKGROUND: Rivaroxaban is a direct inhibitor of coagulation factor Xa and is used for venous thromboembolic disorders. The rivaroxaban interaction with BSA was studied to understand its PK and PD (pharmacokinetics and pharmacokinetics) properties. Multi-spectroscopic studies were used to study the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wani, Tanveer A., AlRabiah, Haitham, Bakheit, Ahmed H., Kalam, Mohd Abul, Zargar, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736510/
https://www.ncbi.nlm.nih.gov/pubmed/29260434
http://dx.doi.org/10.1186/s13065-017-0366-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736510/
https://www.ncbi.nlm.nih.gov/pubmed/29260434
http://dx.doi.org/10.1186/s13065-017-0366-1

Ejemplares similares